CLDX: Celldex Therapeutics Inc
CLDX exchange rate has changed by -3.04% for today. During the day, the instrument was traded at a low of 29.31 and at a high of 30.72.
Follow Celldex Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CLDX News
- Celldex Therapeutics: Trying To Put Its Troubled History Behind It (NASDAQ:CLDX)
- HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $64 Price Target
- Biotech Stocks Dive As Top 2% Names Take Hardest Hit
- Leerink Partners Maintains Outperform on Celldex Therapeutics, Raises Price Target to $88
- The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte
- Morgan Stanley Maintains Overweight on Celldex Therapeutics, Raises Price Target to $57
- Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript
- Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria - Slideshow (NASDAQ:CLDX) 2026-09-22
- Crude Oil Down Over 1%; Thor Industries Shares Gain After Q4 Results
- Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease
- HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $64
- Cantor Fitzgerald Maintains Overweight on Celldex Therapeutics, Raises Price Target to $72
- 4 Biotech Stocks With Key Clinical Readouts Expected This Fall
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Celldex Reports Topline Results From The Company’s Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Trials Evaluating Two Doses Of Barzolvolimab In Patients With Chronic Spontaneous Urticaria; Results Showed Rapid, Profound, Sustained Efficacy, Supporting...
- Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
- Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts (NASDAQ:CLDX)
- Are Medical Stocks Lagging Celldex Therapeutics (CLDX) This Year?
Frequently Asked Questions
What is CLDX stock price today?
Celldex Therapeutics Inc stock is priced at 29.37 today. It trades within 29.31 - 30.72, yesterday's close was 30.29, and trading volume reached 1745. The live price chart of CLDX shows these updates.
Does Celldex Therapeutics Inc stock pay dividends?
Celldex Therapeutics Inc is currently valued at 29.37. Dividend policy depends on the company, while investors also watch 11.00% and USD. View the chart live to track CLDX movements.
How to buy CLDX stock?
You can buy Celldex Therapeutics Inc shares at the current price of 29.37. Orders are usually placed near 29.37 or 29.67, while 1745 and -3.04% show market activity. Follow CLDX updates on the live chart today.
How to invest into CLDX stock?
Investing in Celldex Therapeutics Inc involves considering the yearly range 22.10 - 45.14 and current price 29.37. Many compare -8.96% and -10.73% before placing orders at 29.37 or 29.67. Explore the CLDX price chart live with daily changes.
What are Celldex Therapeutics Inc stock highest prices?
The highest price of Celldex Therapeutics Inc in the past year was 45.14. Within 22.10 - 45.14, the stock fluctuated notably, and comparing with 30.29 helps spot resistance levels. Track Celldex Therapeutics Inc performance using the live chart.
What are Celldex Therapeutics Inc stock lowest prices?
The lowest price of Celldex Therapeutics Inc (CLDX) over the year was 22.10. Comparing it with the current 29.37 and 22.10 - 45.14 shows potential long-term entry points. Watch CLDX moves on the chart live for more details.
When did CLDX stock split?
Celldex Therapeutics Inc has gone through stock splits historically. These changes are visible in , 30.29, and 11.00% after corporate actions.
- Previous Close
- 30.29
- Open
- 30.29
- Bid
- 29.37
- Ask
- 29.67
- Low
- 29.31
- High
- 30.72
- Volume
- 1.745 K
- Daily Change
- -3.04%
- Month Change
- -8.96%
- 6 Months Change
- -10.73%
- Year Change
- 11.00%
- Act
- Fcst
- 198 K
- Prev
- 199 K
- Act
- Fcst
- 1.723 M
- Prev
- 1.710 M
- Act
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%